AI assistant
Sending…
Armata Pharmaceuticals, Inc. — Director's Dealing 2007
May 21, 2007
34152_dirs_2007-05-21_53c1780f-ca6f-4a84-8c39-a8a3e023e6b8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TARGETED GENETICS CORP /WA/ (TGEN)
CIK: 0000921114
Period of Report: 2007-05-17
Reporting Person: COOK JEREMY CURNOCK (Director, Chairman of the Board)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2007-05-17 | Common Stock | A | 15000 | $0.00 | Acquired | 15000 | Direct |
Footnotes
F1: These shares represent a grant of restricted stock units that vest 100% on May 17, 2008, so long as the reporting person is providing services to the issuer on such date.
More from Armata Pharmaceuticals, Inc.
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 27
Board/Management Information
2026
Apr 27
Annual Report
2026
Mar 25
Regulatory Filings
2026
Mar 19
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Regulatory Filings
2026
Feb 23